Concepedia

Author

Roberta Preziosi

University of Perugia

Also Known As

R PREZIOSI, R Preziosi, R. Preziosi, Roberta Preziosi

19

Publications

270

Citations

10

H-Index

17

Concepts

All Affiliations

University of PerugiaUniversity of Bari Aldo MoroOspedale di BelcolleIstituto Superiore di SanitàSapienza University of Rome
RP

About

Roberta Preziosi is an author at University of Perugia specializing in medicine, virology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

32

2

Public Health

1

1

10

3

Epidemiology

1

1

10

4

Hepatology

1

1

10

5

Immunology

1

1

22

Roberta Preziosi

×

9

Publications

243

Citations

9

H-Index

YearCitations

Rapid methods to extract DNA and RNA from<i>Cryptococcus neoformans</i>

Alessandro Bolano, Silvia Stinchi, Roberta Preziosi,

FEMS Yeast Research

2001

96

Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients

Carlo Tascini, Anna Vecchiarelli, Roberta Preziosi,

AIDS

1999

51

Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients

Daniela Francisci, Antonellá Tosti, Roberta Preziosi,

European Journal of Clinical Microbiology & Infectious Diseases

1995

22

Raltegravir Plasma Concentrations in Treatment-Experienced Patients Receiving Salvage Regimens Based on Raltegravir with and without Maraviroc Coadministration

Silvia Baroncelli, P. Villani, Liliana Elena Weimer,

Annals of Pharmacotherapy

2010

16

Rapid methods to extract DNA and RNA from

Alessandro Bolano, Silvia Stinchi, Roberta Preziosi,

FEMS Yeast Research

2001

16

Multicenter Comparison of Three Different Analytical Systems for Evaluation of DNA Banding Patterns from <i>Cryptococcus neoformans</i>

Gianluigi Cardinali, Alessandro Martini, Roberta Preziosi,

Journal of Clinical Microbiology

2002

12

Risk factors for acute parenterally transmitted viral hepatitis: A 20-year study

Daniela Francisci, Sabrina Antonelli, Roberta Preziosi,

European Journal of Epidemiology

1993

10

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors

Raffaella Bucciardini, Gabriella d’Ettorre, Silvia Baroncelli,

International Journal of STD & AIDS

2012

10

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

LE Weimer, Vincenzo Fragola, Marco Floridia,

Journal of Antimicrobial Chemotherapy

2012

10

Page 1